Some investors asked on the investor interaction platform: has the company’s heart valve business started clinical trials in China? It is said that the sales of the company’s new bracket exceeded the target in the first quarter. What is the sales purpose of the new bracket this year?
Blue Sail Medical Co.Ltd(002382) ( Blue Sail Medical Co.Ltd(002382) . SZ) said on the investor interaction platform on April 30 that the clinical practice of Chinese valves is advancing in an orderly manner. The company has set an annual sales target for biofreedomtm stents, made every effort to promote the admission work, and strive to benefit more patients with this unique stent product with high bleeding risk indications in the Chinese market. Please pay attention to the regular report on the specific sales.
